Showing 311-320 of 8647 results for "".
Alcon Announces Plans to Acquire Lensar
https://modernod.com/podcasts/eyewire-news-the-podcast/alcon-announces-plans-to-acquire-lensar/37077/Alcon makes a major acquisition to bolster its cataract surgery portfolio; Opthea releases phase results for its combination wet AMD candidate; and Bausch + Lomb announces results from a phase 4 extension study of dry eye disease drug Miebo. Learn more about your ad choices. Visit megaphone.fm/adchoSpecial Report – Increasing Access to Care Through the Cure Blindness Project
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-increasing-access-to-care-through-the-cure-blindness-project/37067/Leaders from Cure Blindness Project discuss efforts to restore vision and prevent avoidable blindness in underserved communities around the world. Learn more about your ad choices. Visit megaphone.fm/adchoicesB+L Bolsters Glaucoma Offerings with Elios Acquisition
https://modernod.com/podcasts/eyewire-news-the-podcast/bl-bolsters-glaucoma-offerings-with-elios-acquisition/37063/Bausch + Lomb makes an acquisition to expand its glaucoma offerings; Roche gets a major approval in Europe for Vabysmo; and EssilorLuxottica buys a maker of noninvasive ophthalmic medical devices. Learn more about your ad choices. Visit megaphone.fm/adchoicesSpecial Report: OWL Celebrates 20th Anniversary
https://modernod.com/podcasts/eyewire-news-the-podcast/special-report-owl-celebrates-20th-anniversary/37060/Executives from Ophthalmic World Leaders discuss the history and goals of thee organization as it celebrates its 20th anniversary. Learn more about your ad choices. Visit megaphone.fm/adchoicesLLLT and AMD: Your Questions Answered
https://modernod.com/topics/retina/lllt-and-amd-your-questions-answered/37350/Joseph J. Allen, OD, FAAO, Dipl ABO, gives an overview of a recently FDA-authorized low-level light therapy, or photobiomodulation, device, the Valeda Light Delivery System (LumiThera). He explains the device’s unique mechanism of action for treating age-related macular degeneration, reviews promisiThe Future Is Here: AI in Eye Care
https://modernod.com/topics/technology/the-future-is-here-ai-in-eye-care/38898/The successful incorporation of an AI system into practice could revolutionize patient care.84. Case Reflection: Contact Lens Abuser
https://modernod.com/podcasts/four-eyes/84-case-reflection-contact-lens-abuser/37034/In this episode of our New Grad Case Reflection series, we dive into the challenges of managing a patient who consistently abused their contact lens wear. Patient education on contact lens hygiene is vital, but what happens when they ignore your advice? Join Dr. Bilkhu as she reflects on her experieBreaking News From the AAO Meeting in Chicago
https://modernod.com/podcasts/eyewire-news-the-podcast/breaking-news-from-the-aao-meeting-in-chicago/37055/Eyewire News: The Podcast reports on new products and breaking news live from the American Academy of Ophthalmology meeting in Chicago.Two Partnerships Formed to Advance Glaucoma Treatments
https://modernod.com/podcasts/eyewire-news-the-podcast/two-partnerships-formed-to-advance-glaucoma-treatments/37051/Two collaborations are made to develop and market new glaucoma treatments; Apellis receives feedback from a committee of thee EMA for its geographic atrophy treatment pegcetacoplan; and Topcon receives FDA clearance for OCTA on the company’s Maestro2 fundus camera system.Weekly Headlines: First Therapy for Acanthamoeba Keratitis Approved in Europe
https://modernod.com/podcasts/eyewire-news-the-podcast/eyewire-news-09042024/37048/First Therapy for Acanthamoeba Keratitis Approved in Europe • Oculus Adds Dual Testing Functionality to Easyfield VR • FDA Clears IND Application for Stem Cell Therapy for Primary Photoreceptor Diseases